Robert W Rubin Phd
Lovelace Biomedical listed Robert W Rubin Phd as CEO (THROUGH 5/31/25) on its 2024 Form 990.
Reported compensation by filing year
Each entry comes from one tax return. Bar lengths compare reported compensation across filings.
Tax year
Reported total$845,514
- From filing organization
- $782,222
- From related organizations
- $0
- Other compensation
- $63,292
Tax year
Reported total$941,935
- From filing organization
- $874,428
- From related organizations
- $0
- Other compensation
- $67,507